BioMaterials Korea, Inc.
BioMaterials Korea, Inc. was established in 2003 as a venture business, which has been developing and manufacturing products for biomedical applications giving priority to orthodontics. Continuous researches have led BMK to make remarkable advancements in the use of raw materials such as Ti-Ag, Ti-Au, Ti-Ag-Cu, NiTi-Ag alloys. Surface treatment of biomaterials is another competitive advantage BMK has over the competitions. With research and knowledge of orthodontic treatment, BMK has introduced new ways to biomaterials. BMK takes great pride in its designs of the products. The representative products of BMK are orthodontic mini-implant systems and they have been approved of their quality and functions by orthodontists worldwide. BMK has performed a number of Korean governmental projects, obtained certificates of ISO 9001/13485 and KGMP for systematic production. Most of its products have been certified by FDA, CE MDD and MHLW(in Japan). All manufactured products are inspected to meet the international standards. BMK gives priority to HIGH-END quality and functionality in construction of its products line. Since BMK staffs have been well experienced on materials and clinical conditions both in theory and practice from omni-directional fields concerned, the products are always on the top level in worldwide market. BMK has a CDMA (clinician-demand-manufacturer-answer) system, a number of clinicians/professors up front and the researchers of BMK keep introducing the market to novel products. Cooperation with universities and clinicians also helps in promoting the products and BMK has ascertained it in the domestic market and the foreign market.